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ABSTRACT
The translation factor eIF5 is an important partner of
eIF2, directly modulating its function in several
critical steps. First, eIF5 binds eIF2/GTP/
Met-tRNAi
Met ternary complex (TC), promoting its
recruitment to 40S ribosomal subunits. Secondly,
its GTPase activating function promotes eIF2 dis-
sociation for ribosomal subunit joining. Finally,
eIF5 GDP dissociation inhibition (GDI) activity can
antagonize eIF2 reactivation by competing with the
eIF2 guanine exchange factor (GEF), eIF2B. The
C-terminal domain (CTD) of eIF5, a W2-type HEAT
domain, mediates its interaction with eIF2. Here,
we characterize a related human protein containing
MA3- and W2-type HEAT domains, previously
termed BZW2 and renamed here as eIF5-mimic
protein 1 (5MP1). Human 5MP1 interacts with eIF2
and eIF3 and inhibits general and gene-specific
translation in mammalian systems. We further test
whether 5MP1 is a mimic or competitor of the GEF
catalytic subunit eIF2Be or eIF5, using yeast as a
model. Our results suggest that 5MP1 interacts
with yeast eIF2 and promotes TC formation, but
inhibits TC binding to the ribosome. Moreover,
5MP1 is not a GEF but a weak GDI for yeast eIF2.
We propose that 5MP1 is a partial mimic and com-
petitor of eIF5, interfering with the key steps by
which eIF5 regulates eIF2 function.
INTRODUCTION
During translation initiation, eukaryotic initiation factors
(eIFs) assemble initiator methionyl tRNAi
Met
(Met-tRNAi
Met) and m
7G-capped mRNA with the 40S
ribosome subunit, precisely matching the tRNAi
Met anti-
codon to the mRNA start codon at the 40S ribosomal
P-site (1,2). This translation process occurs in multiple
steps. First, the heterotrimeric factor eIF2 (composed of
a, b and g subunits) binds Met-tRNAi
Met, a process that is
dependent on GTP being bound to the g subunit of eIF2.
The resulting eIF2/GTP/Met-tRNAi
Met ternary complex
(TC) is incorporated into the 43S pre-initiation complex
(PIC), which also contains eIF1A, eIF1, eIF3 and eIF5.
The m
7G-capped mRNA is then activated and is recruited
to the 43S PIC by eIF4F, composed of the cap binding
protein eIF4E, adaptor eIF4G and mRNA helicase
eIF4A, forming the 48S PIC that includes the 40S
subunit located at the 50-end of the mRNA. The PIC
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start codon of the mRNA base-pairs to the tRNAi
Met
anticodon in the P-site of the ribosome. The concerted
actions of the assembled eIFs coupled to the eIF2
GTPase activation (GAP) function catalyzed by the
N-terminal domain (NTD) of eIF5 are thought to
provoke conformational changes within the PIC,
promoting the release of most eIFs, including eIF1, eIF2
and eIF5. The second GTP binding factor eIF5B then
mediates the joining of the 60S subunit to form an 80S
initiation complex, which is then ready to accept the
second aminoacyl tRNA into the ribosomal A-site
during the elongation phase of translation. eIF2 is
released from the PIC as the GDP-bound form, which is
reactivated to the GTP-form by eIF2B-catalyzed guanine
nucleotide exchange, allowing for subsequent rounds of
translation initiation. eIF5 appears to be ejected from
the PIC in complex with eIF2-GDP, and antagonize
eIF2B-catalyzed eIF2 reactivation (3) via its GDP dissoci-
ation inhibition (GDI) activity (4).
Many critical protein–protein interactions mediating
the eukaryotic translation initiation process involve the
HEAT domain, a globular domain comprising several
repeats of conserved anti-parallel a-helical structures (5).
For example, mammalian eIF4G molecules possess three
distinct HEAT domains termed MIF4G, MA3 and W2
(Figure 1A). The MIF4G and MA3 domains of eIF4G
together form a binding pocket for a single molecule of
eIF4A, thereby regulating mRNA recruitment and
scanning (6), whereas the last W2 domain is the binding
site for Mnk eIF4E kinase (7) (Figure 1A). Mammalian
eIF4G also possesses an unstructured N-terminal segment
capable of binding poly(A) binding protein (PABP) and
the m
7G-cap binding subunit, eIF4E. W2-type HEAT
domains (W2-CTDs) are also found in the C-terminal
segments of eIF5 and eIF2Be but these are substrate
binding sites for the lysine-rich N-terminal half of the
eIF2b subunit (8,9). The role of W2-CTDs of eIF5 and
eIF2Be in the regulation of eIF2 activity has been
well-established. The W2-CTD of eIF2Be functions in
guanine nucleotide exchange on eIF2 (10), whereas the
W2 domain in eIF5 mediates the formation of a
multifactor complex (MFC) with eIF1, eIF2-GTP, eIF3
and Met-tRNAi
Met (9,11). Finally the eIF5 W2-CTD
together with the adjacent N-terminal linker region is re-
sponsible for the GDI activity against eIF2-GDP (3,4).
Two distinct copies of eIF4G are found in most eukary-
otes examined so far. However, vertebrates encode a third
eIF4G-like species termed p97/NAT1/DAP5 (Figure 1A).
This protein lacks the N-terminal segment but contains
the three HEAT domains analogous to mammalian
eIF4G. Thus, p97/NAT1/DAP5 is a macromolecular
Figure 1. HEAT domain-containing translation initiation factors and regulators. (A) Primary structures of human eIF4G1, p97/NAT1/DAP5,
5MP1/BZW2 and yeast eIF2Be and eIF5 are drawn to scale with ﬁlled boxes indicating segments known to interact with their partners listed
across the top. Bracket indicates an approximate area of interaction with indicted partners. Light gray boxes indicate the W2 domains, with short
thick lines representing the location of AA-boxes 1 and 2 (AA-1, AA-2, respectively). Gray boxes indicate other HEAT domains. (B) Alignment of
C-terminal parts of amino acid sequences (starting with residue numbered to the left) from human 5MP1/BZW2 and 5MP2/BZW1/BZAP45.
Asterisks indicate residues making up AA-boxes, while vertical arrows indicate mutations in 7A. Horizontal arrows indicate the location of
a-helices predicted from the homology with eIF4G.
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been implicated in the modulation of translation for
speciﬁc mRNAs (14). Interestingly the DAP5-CTD 3D
structure is very similar to that of the W2-CTDs of eIF5
and eIF2Be, and in common with these factors, but unlike
eIF4G, DAP5 also binds to eIF2b (15).
In this study, we characterize another human HEAT
domain-containing protein that is related to eIF5,
known as BZW or MA3+W2 protein (Figure 1A) (16).
Human BZW1 and BZW2 share 72% sequence identity
and contain two HEAT domains, MA3 and W2 (hence the
family name), comprising 10 and 8 a-helices that corres-
pond to ﬁve and four HEAT repeats, respectively (http://
famshelp.gsc.riken.jp/famsbase). While BZW1 was
characterized as a transcription factor termed BZAP45
(17), its GFP-fusion form is localized in the cytoplasm
(18). In addition, a single MA3+W2 protein is found in
Drosophila melanogaster and is termed Krasavietz (Kra)
(also known as eIF5C, Exba, or Ecp). Lee et al. (19) pre-
sented evidence that Kra co-migrates with 40S ribosomes
and interacts with eIF2b more weakly than eIF5, and that
Kra AA-box 1 and 2 mutations weaken this interaction
with eIF2b. Furthermore, Kra reduces luciferase expres-
sion in rabbit reticulocyte lysate (RRL) (19). Interestingly,
the Drosophila Kra mutants are defective in long-term
memory (20) and consistent with this, Kra is implicated
in neuronal development and interacts with Shot, the cyto-
skeletal element that links F-actin and microtubules
required for axon formation (19).
The above-mentioned study of Kra protein suggests
that all W2-containing proteins (eIF5, eIF2Be, p97/
NAT1/DAP5 and BZW/Kra), except eIF4G, bind eIF2.
Because the eIF5-NTD that activates eIF2 GTPase in
response to start codon selection is not present in the
BZW proteins (Figure 1A), we hypothesized that BZW/
Kra may serve as a mimic or competitor of eIF2Be or an
antagonist of eIF5 functions in translation. Here we tested
these predictions and provide evidence from multiple
systems (RRL, mammalian cells and yeast) that BZW2
does indeed antagonize eIF5 functions with eIF2 to
modulate both general translation and the translation of
speciﬁc genes at multiple steps. BZW stands for basic
leucine-zipper with a W2 domain, although the conserved
lysine/arginine and leucine residues that were
characterized as basic leucine-zipper (17) are in fact a
part of HEAT repeats that make up a MA3 domain
(16). Based on this study emphasizing its role as a com-
petitive inhibitor of eIF5 function by macro-molecular
mimicry, we thus designate the BZW proteins as the
eIF5-mimic proteins (5MPs), and rename human BZW2
and BZW1 as 5MP1 and 5MP2, respectively.
MATERIALS AND METHODS
Plasmids and yeast strains
Plasmids used in this study and oligodeoxyribonucleotides
used for their constructions are listed in Supplementary
Tables S1 and S2, respectively. Details of their construc-
tion and yeas strains used are described in Supplementary
Data.
Yeast methods
We used the standard genetic/ molecular biology tech-
niques and prepared yeast growth media. Immuno-
afﬁnity puriﬁcation of FLAG-tagged protein complexes
was performed as described (3,11,21).
In vitro protein–protein interaction assay
eIF3 and eIF2 were puriﬁed from HeLa cells (kindly
provided by J. Hershey and M. Sokabe). FL-5MP1 and
its mutants were puriﬁed from H2557 transformants
carrying pEMBL-FL-5MP1 and its derivatives, that
had been grown in synthetic complete galactose me-
dium lacking uracil (SCGal-ura), as described
(22). Recombinant eIF5 was puriﬁed by G50 column frac-
tionation after thrombin treatment of GST-human eIF5
(23).
To perform GST pull-down assays, GST-fusion
proteins were expressed in BL21(DE3) transformants
carrying the relevant pGEX- series of plasmids
(Table S1), puriﬁed in one-step with a glutathione resin
and used immediately for the interaction with their
puriﬁed partners, essentially as described (24). In each ex-
periment and its repeats, we used a ﬁxed amount of
GST-fusion proteins (5mg each of GST, GST-5MP1 and
GST-5MP1-7A in Figure 2A and D; 5mg GST, 3mg each
of GST-eIF2a and -eIF2b in Figure 2B) and 10 times less
(in molarity) puriﬁed partners. For the latter, we used 1mg
human eIF2 (Figure 2A) or 8mg human eIF3 (Figure 2D),
or 300ng of FL-5MP1 or FL-5MP1-7A (Figure 1E). After
incubation, protein complexes adsorbed to the resin were
washed, dissolved into a SDS–PAGE buffer and analyzed
by immunoblotting.
Analysis of 43S/48S PIC in RRL
m
7G-capped luciferase mRNA was synthesized and
puriﬁed using the mMegascript mMessage kit (Ambion)
and SmaI-linearized plasmid pRG166 as template (25).
Translation reaction (20ml) was performed with RRL in
the presence of cold amino acids using 2.5ng cap-LUC
mRNA, as recommended by the manufacturer
(Promega). After incubation at 30 C for 20min, the
sample was supplemented with 160ng BSA or FL-5MP1
and incubated for an additional hour. The samples were
ﬁxed with 1% HCHO on ice for 30min, quenched with
0.1M glycine and layered on 5–40% sucrose gradient con-
taining 20mM Tris–HCl (pH 7.5), 100mM NaCl and
1mM MgCl2. After ultracentrifugation at 39000rpm for
4.5h, the gradient sample was fractionated by ISCO
gradient fractionator. The top nine fractions were
precipitated and analyzed by immunoblotting, together
with an in-put control and puriﬁed recombinant eIF5 as
references.
Polysome proﬁling of the HeLa cells
HeLa cells grown in 6-cm petri dish containing 2ml
complete Dulbecco’s modiﬁed Eagle’s medium
(D-MEM, GIBCO) supplemented with 10% fetal bovine
serum (GIBCO) were transfected with indicated plasmids
using PolyFect Transfection Reagent (QIAGEN), and
8316 Nucleic Acids Research, 2011,Vol.39, No. 19after 24h, the medium was replaced with 2ml D-MEM
(no serum) and the cells were incubated for additional
24h. Then FBS (GIBCO) was added to 10% and the
cells were collected for polysome proﬁling after 20min.
The collected cells (4 10
6 cells) were lysed in 500ml lyse
buffer (20mM HEPES, pH 7.5, 100mM KCl, 10mM
MgCl2, 0.25% NP-40, 100mg/ml cycloheximide,
100U/ml RNase inhibitor, protease inhibitor cocktail)
by passing through a sterile syringe with a 26 or 27
gauge needle several times. Then the lysate was cleared
by a brief centrifugation (10000g, 5min) to remove
non-ribosomal nuclear components, which otherwise
increase the base-line of the proﬁle towards the bottom
of the gradient. Subsequently, 400ml of the cleared lysate
was layered on 5ml 10–45% sucrose gradient (20mM
HEPES, 100mM KCl, 10mM MgCl2) in 151–513 tubes
and fractionated by centrifugation at 40000rpm for 1h at
4 C in a Beckman MLS-50 rotor. The gradient was
analyzed by the Biocomp Piston Gradient
Fractionator
TM. The reminder of the lysate was used for
checking the total protein yield by the Lowry method and
immunoblotting with anti-RPL7 antibodies. As shown by
anti-RPL7 immunoblot in Figure 4B, the total ribosome
content of the lysate was not altered signiﬁcantly by ex-
pression of 5MP1 under the conditions examined. We also
conﬁrmed by immunoblotting with these antibodies that
the above-mentioned treatment of clearing the lysate does
not affect the amount of ribosomes in the lysate and that
the area shown by bracket in Figure 4C covers the entire
polysome. Thus, the lysate clearing is essential in
evaluating polysome abundance in mammalian cultured
cells by densitometry under our experimental conditions.
Figure 2. Human 5MP1/BZW2 interacts with eIF2 and eIF3. (A) Pulldown assays with GST-5MP1 (W, wild-type), its 7A derivative (7A) or GST
alone (C). The complexes with human eIF2 were analyzed with 10% in-put (In) control by immunoblotting using anti-eIF2a (Santa Cruz Biotech.)
(top gel) followed by Ponceau S staining (bottom gel). Arrows in the bottom gel indicate the location of GST-fusions used. Lanes i and iii, size
standards. Lane ii, human eIF2 used visualized by Coomassie staining. Graph summarizes percentage of eIF bound to GST-fusions used, with bars
indicating SD. (B) Interactions of 5MP1 with individual eIF2 subunits fused to GST. GST-eIF2a (2a), and -eIF2b (2b) bound to FL-5MP1 (wt) or
its 7A version (7A) were analyzed with 2.5% in-put (lanes 1) by immunoblotting (top gels) with anti-FLAG M2 antibodies (Sigma), followed by
Ponceau S staining shown on bottom and presented as in (A). C, control with GST alone. Graph indicates the percentage of FL-5MP1 or
FL-5MP1-7A bound to GST-eIF2b, with bars denoting SD. (C) Competition assay. FL-5MP1 (200ng) and/or human eIF5 (1.6mg) were incubated
with GST-heIF2b (2b) or GST alone (C) (1mg) pre-adsorbed to glutathione resin, and the complex was precipitated and analyzed by immunoblotting
with anti-GST (top), anti-FLAG (middle) and anti-heIF5 (bottom) antibodies, as in (A). Lane 1, 5% in-put of heIF5. Lane 2, 25% in-put of
FL-5MP1. (D) Pulldown assays with GST-5MP1 and its 7A derivative (7A) were performed with human eIF3, similar to (A), and analyzed with 50%
in-put (In) control by immunoblotting using anti-eIF3e (41) antibodies (top gel), followed by Ponceau S staining (bottom gel). The results were
presented as in (A). In the ‘in-put’ lane, eIF3 subunit names are identiﬁed to the right. Graphs summarize the percentage of eIF3 bound to
GST-fusions used, with bars indicating SD.
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Details of ATF4 expression assay were reported previously
(26). Brieﬂy, MEF cells homozygous for eIF2 -S51A
mutation obtained from Randall Kaufman (University
of Michigan, Ann Arbor) were immortalized by infection
of a recombinant retrovirus expressing simian virus 40
large T antigen. MEF cells were grown in 24-well plates
in D-MEM (BioWhittaker) supplemented with 10% FBS,
2mM glutamine, 1mM nonessential amino acids, 100
units of penicillin per ml and 100mg of streptomycin per
milliliter. Plasmid transfections were performed by using
the MEF cells at 40% conﬂuency and the FuGENE
tranfection reagent (Roche Applied Science).
Cotransfections were carried out in triplicate by using
the pCDNA plasmids, the TK-ATF4-Luc fusion plasmid
(p759) and a Renilla luciferase plasmid (p851) serving as
an internal control (Promega). After transfection (40h),
MEF cells were treated with thapisgargin (Tg) at
0.1mM, for 6h or with no ER stress. Dual luciferase
assays were carried out as described by the Promega in-
struction manual (cat #E1960). Values shown in Figure
4D are a measure of a ratio of ﬁreﬂy versus Renilla
luciferase units (relative light units, RLU), and represent
the mean values of three independent transfections. We
reproducibly obtained similar levels of Renilla LUC
activity in wild-type and eIF2a-S51A MEFs, unless trans-
lation is strongly perturbed e.g. by high dose of Tg. Thus,
the transfection efﬁciency is stable under our experimental
conditions. At least two sets of independent experiments
were performed to conﬁrm reproducibility.
Fluorescent microscopy
Live yeast cells were mounted onto 0.5% poly-L-lysine–
coated slides and visualized on a Leica SP5 confocal
microscope with a 63 0.6–1.40NA Plan Apochromat
oil objective (Leica). Images were acquired using
Application suite 1.6.3 (Leica). For densitometric
analysis, a merged  80 Z-series projection image was
taken and analyzed using NIH ImageJ software. For
data analysis, we took Z-projection images of cells from
at least three independent mid-log cultures that had been
grown in SCGal-ura.
RESULTS
5MP1 interacts with human eIF2 and eIF3 in vitro
We ﬁrst wished to test if the human 5MP1 protein binds to
eIF2. For this purpose, we incubated eIF2 puriﬁed from
HeLa cells (Figure 2A, lane ii) with glutathione resin
pre-adsorbed with GST-5MP1 fusion protein, or with
GST alone. Associated proteins were then analyzed by
immunoblotting with anti-eIF2a antibodies. eIF2a was
detected in the complex with GST-5MP1 (Figure 2A,
lane 3, top gel); thus, GST-5MP1 interacts with human
eIF2. To test if the 5MP1 interaction with eIF2 depends
on AA-boxes that characterize the W2 domain
(Figure 1B), we introduced 7 alanine-substitutions to the
AA-box 2 of GST-5MP1. This mutation, here called
5MP1-7A, reduced the interaction between GST-5MP1
and eIF2 by >2-fold (P=0.027, n=4) (Figure 2A, lane
4; quantiﬁed in the graph on top). This shows that
AA-box 2 of 5MP1 contributes to the eIF2 binding site
similar to the AA-box motifs in eIF5, eIF2Be and Kra.
Because eIF5, eIF2Be and Kra interact with eIF2 via
the eIF2b subunit (8,19,27), we also examined if 5MP1
binds directly to eIF2b. As shown in Figure 2B (top gel)
puriﬁed FLAG-tagged 5MP1 (FL-5MP1) bound speciﬁc-
ally to GST-fused human eIF2b (GST-eIF2b), but not to
GST-fused human eIF2a (lanes 2–4). Again, the 7A
mutation in 5MP1 reduced its interaction with
GST-eIF2b by 2-fold (P=0.002, n=6) (Figure 2B,
lower gel and graph). Thus, 5MP1 interacts with eIF2b
at least partially via its AA-box 2 motif, suggesting eIF2b
represents a major site of interaction between 5MP1 and
eIF2.
Since the observed interaction between 5MP1 and
eIF2b proceeds via the same AA-box 2 motif as eIF5
uses to bind eIF2b, we hypothesize that 5MP1 and eIF5
may compete with each other for binding to eIF2b. To test
this idea directly in vitro, we incubated GST-eIF2b with
5MP1 and eIF5, alone or in combination. As shown in
Figure 2C (middle gel), human eIF5 outcompeted the
binding of FL-5MP1 to GST-eIF2b (compare lanes 6
and 8). Interestingly, the amount of human eIF5 bound
to GST-eIF2b was also reduced by the presence of
FL-5MP1 (Figure 2C, bottom gel, lane 8), even though
eight times more eIF5 than FL-5MP1 was present. This
suggests that interactions of eIF2b with eIF5 and 5MP1
are mutually exclusive, and 5MP1 may act as a competi-
tive inhibitor of eIF5.
The eIF5 W2 domain also interacts with eIF3.
Therefore, we next examined whether 5MP1 could also
bind to puriﬁed eIF3. The eIF3 preparation used here
contains all 13 subunits including eIF3e subunit, which
was used for immunodetection of eIF3 in this study. As
shown by immunoblotting with anti-eIF3e, eIF3 speciﬁc-
ally co-precipitated with GST-5MP1 but not with GST
alone (Figure 2D, lanes 1 and 2). The absence of
anti-eIF3e signals with GST-5MP1 or -5MP1-7A alone
conﬁrms the authenticity of the eIF3 subunit detected
here (lanes 4 and 5). Importantly, this interaction was
not compromised by the AA-box 2 mutation in the
5MP1-7A protein (lanes 2 and 3, see graph to the right
for quantiﬁcation), indicating that this mutation speciﬁc-
ally affects the interaction with eIF2. These results
together indicate that 5MP1 can interact with both eIF2
and eIF3, similar to the eIF5 W2 domain.
5MP1 inhibits translation in RRL
Next, we examined the effect of 5MP1 on protein synthesis
using a cell-free RRL translation assay. As shown in
Figure 3A (inset), puriﬁed FL-5MP1 repressed
35S-luciferase synthesis in RRL programmed with
capped luciferase (LUC) mRNA (lane 2), while the
addition of equivalent amount of BSA did not (lane 1).
The titration experiments in Figure 3A indicated that
 40ng or 0.8pmol of FL-5MP1 is required for nearly
full inhibition: Because the RRL used here contains 7
8318 Nucleic Acids Research, 2011,Vol.39, No. 19and 3pmol of eIF2 and eIF5, respectively (data not
shown), translational inhibition by 5MP1 is quite efﬁcient.
To address the mechanisms by which 5MP1 can inhibit
translation in RRL, we fractionated RRL programmed
for luciferase mRNA translation with or without
FL-5MP1 by sucrose gradient–velocity sedimentation.
As shown in Figure 3B, anti-eIF2a immunoblot of
gradient fractions of control RRL revealed that eIF2
was across the gradient; however, there was a speciﬁc
peak indicating eIF2 comigration with the 40S subunit
(panel 1). The amount of eIF2 comigrating with the 40S
was not signiﬁcantly affected by 5MP1 addition to RRL
(Figure 3B, panels 1 and 2), a trend that was conﬁrmed
among many repeated experiments. Importantly, the
addition of FL-5MP1 reduced eIF5 binding to the
ribosome to levels that were not detectable (Figure 3B,
panels 1 and 2). The eIF5 comigration with the 40S
subunit in the control RRL appears to reﬂect speciﬁc
interaction, as the 40S fractions do not contain mRNA
helicase eIF4A, which does not bind stably to the 40S
subunit (Figure 3B, panels 1 and 2). Instead, we found
that FL-5MP1 appeared to comigrate with the 40S
subunit (Figure 3B, panel 2, bottom panel) at a level
equivalent to that of eIF5 in the control RRL (panel 1).
These results, combined with the competition experiments
shown in Figure 2D, suggest that 5MP1 may competi-
tively inhibit eIF5 recruitment to the 40S subunit.
Human 5MP1 is capable of repressing translation and
modulating ATF4 expression in mammalian cells
To express 5MP1 in mammalian cells, we cloned 5MP1
and its GFP-fusion and 7A mutant derivatives under a
CMV promoter (pCDNA-5MP1 and derivatives in
Supplementary Table S1). Transfection of 5MP1-GFP
led to cytoplasmic GFP localization as judged by ﬂuores-
cent microscopy (Figure 4A), in agreement with the cyto-
plasmic location of 5MP2/BZW1 reported previously (18).
pCDNA-5MP1 and its derivatives express a similar level
of 5MP1 in transfected HeLa cells (Figure 4B), and im-
munoblotting indicated that the expressed 5MP1 proteins
were found speciﬁcally in the cytoplasmic, but not in the
nuclear fractions of HeLa cell extracts (data not shown).
The transfection of pCDNA-5MP1 expressing 5MP1
alone led to a small reduction in the polysome content
of the cells, especially the highly sedimenting polysomes
(Figure 4C, compare panels 1 and 2). Given that 5MP1 is
cytoplasmic and its expression impacts upon polysome
proﬁles, the data are consistent with the idea that 5MP1
modulates translation in mammalian cells.
The relatively weak effect of enhanced 5MP1 expression
upon general protein synthesis (Figure 4C) led us to
address whether elevated 5MP1 changes the translation
of speciﬁc mRNAs. ATF4 mRNA is translationally
enhanced by phosphorylation of eIF2 in response endo-
plasmic reticulum (ER) stress, a process that can be trig-
gered by addition of the well-characterized ER stress agent
thapsigargin (Tg) (28). The regulation of ATF4 translation
depends on its upstream open reading frames (uORFs). In
short, ATF4 translation requires prior translation of
uORF1, resumed 40S scanning, bypassing of uORF2
and re-initiation at ATF4 AUG, whereas re-initiation at
uORF2 prevents subsequent translation of ATF4 (28).
This choice is modulated by eIF2 phosphorylation,
which transforms eIF2 into a competitive inhibitor of
eIF2B, thereby reducing the cellular eIF2-GTP/
Met-tRNAi
Met (TC) level and delaying TC binding to
the re-initiating 40S subunit. This allows uORF2 to be
bypassed during times of stress and instead, promotes
re-initiation at ATF4 located downstream. Thus, if
Figure 3. 5MP1/BZW2 inhibits cell-free translation in RRL.
(A) Cell-free translation of
35S-luciferase (LUC) was performed in the
presence of different amounts of indicated proteins in 10ml RRL
programmed with 1.25ng capped LUC mRNA. The reaction was run
at 30 C for 1h in the presence of [
35S]-methionine. Inset shows auto-
radiography indicating the amount of LUC production. Graph shows
the plot of relative
35S-LUC synthesis against the amount of proteins
added from at least three independent experiments, with bars indicating
SD. (B) RRL programmed with cap-LUC mRNA was supplemented
with 160ng BSA (panel 1) or FL-5MP1 (panel 2) and incubated for 1h.
The samples were ﬁxed with HCHO and resolved by sucrose
gradient-velocity sedimentation. Fractions were analyzed by immuno-
blotting with antibodies indicated to the right. In, 10% in-put RRL
used. The amounts of eIF5 or FL-5MP1 (in picomoles) associated with
the 40S subunit are listed to the bottom of the gel.
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alter re-initiation and affect ATF4 expression in the
absence of eIF2 phosphorylation.
ATF4 expression was measured by ﬁreﬂy luciferase
activity from a transiently transfected ATF-LUC plasmid
and was normalized by Renilla luciferase activity ex-
pressed from a second co-transfected plasmid. In mouse
embryonic ﬁbroblasts (MEF) containing an alanine
mutation in the serine-51 phosphorylation site of eIF2a
(eIF2a-S51A) there is no induction of ATF4-regulated
luciferase activity in response to ER stress, emphasizing
the speciﬁcity of this translational control (Figure 4D,
Columns 1 and 2). As a control, the same Tg treatment
induced ATF4 expression >3-fold in MEF with wild-type
eIF2a (eIF2 -S51
+) (Figure 4D, Columns 7 and 8).
Expression of 5MP1 signiﬁcantly increased the level of
ATF4 translation in the eIF2a-S51A cells independent of
stress treatment (Figure 4D, Columns 3 and 4). However,
5MP1 expression did not increase ATF4 expression in the
eIF2 -S51
+ cells (Figure 4D, Columns 9 and 10).
Interestingly, the increase in ATF4 expression observed
here with enhanced 5MP1 expression was alleviated par-
tially by the 7A mutation, and was observed to be
independent of Tg treatment (Figure 4D, lanes 5 and 6).
These results suggest that the alteration in 5MP1 inter-
action via the AA-box 2, perhaps with eIF2, can
modulate ATF4 translation by affecting TC activity or
recruitment in mammalian cells.
Human 5MP1 can inhibit GDP dissociation from yeast
eIF2
The data described thus far are consistent with the idea
that 5MP1 can modulate translation initiation by binding
to eIF2 and competitively excluding eIF5 through its W2
HEAT domain. This is consistent with a major function of
the W2-CTD, which is to bridge the interaction between
eIF2 and eIF3, hence mediating the formation of the
MFC also containing eIF1 (11). Because the eIF5 GAP
function requires the NTD that is not conserved in 5MP/
BZW (30) it appeared highly unlikely that 5MP1 was a
functional GAP, so this activity was not assessed.
However, the W2-CTD of yeast eIF5, together with its
juxtaposed linker region (LR), has also been described
to inhibit GDP dissociation from eIF2: GDI activity (4).
This activity opposes the guanine nucleotide exchange
activity of eIF2B by stabilizing GDP binding. While our
data so far suggest that 5MP is a competitive inhibitor of
eIF5 function in promoting translation, because
theW2-type HEAT domains (W2-CTD) of eIF2Be, p97/
NAT1/DAP5 and eIF5 are structurally similar to that of
5MP (Figure 1) and all interact with eIF2, it was also
possible that 5MP1 is a mimic of eIF2Be or acts to func-
tionally replace this factor. Indeed, the W2-CTD of
eIF2Be is the catalytic domain that can function alone
in a direct GEF assay (10). Therefore by assessing
whether 5MP1 affects GDP dissociation, we were able
to directly assess if it mimics either GEF (accelerates
GDP release) or GDI (retards GDP release) functions of
eIF2Be and eIF5, respectively. For this purpose, we
puriﬁed GST-5MP1 and its 7A mutant derivative and
examined their effect on GDP retention by yeast eIF2 in
a standard assay examining the dissociation of [
3H]GDP
from puriﬁed eIF2. As shown in Figure 5A, GDP dissoci-
ation was modestly, but signiﬁcantly, reduced by wild-
type 5MP1, but not by 5MP1-7A. Since GDP dissociation
was not increased, as has been observed by adding
eIF2Be (10), this result indicates that 5MP1 is not a func-
tional mimic of eIF2Be. The retardation of GDP
Figure 4. 5MP1/BZW2 controls general and ATF4-speciﬁc translation
in mammalian cells (A) Fluorescence emitted from 293T cells trans-
fected with pCDNA-5MP1-GFP. (B) HeLa cells were transfected with
plasmids indicated across the top and subjected for immunoblotting
with antibodies indicated to the right. Anti-RPL7 was used as
loading control. (C) Polysome proﬁles of serum-activated HeLa cells
transfected with pCDNA-5MP1 (panel 2) or pT7-GFP control (panel
1) were monitored as described (29) with the P/M ratio presented on
top right. Dotted line indicates an arbitrary base-line used to calculate
P/M ratio. Identical base-line and scale in y axis were set for each set of
experiments for accurate comparison. (D) Effect of 5MP1/BZW2 on
ATF4 expression. Wild-type (eIF2 -S51
+) MEF (Columns 7–10) or
MEF homozygous for eIF2 -S51A (Columns 1–6) were triple-
transfected with ATF4-luc, Renilla luciferase plasmind, and an empty
vector (Vec), pCDNA-5MP1 (WT) or  7A (7A), treated with (+) or
without ( ) 0.1mM Tg, and assayed for luciferase expression. Graphs
in (D) show the ratio of expression from ATF4-luc to that from the
Renilla luc with bars indicating SD (n=3). These are a typical result of
reproduced experiments.
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(yeIF5) (Figure 5A). Thus, 5MP1 appears to act as a
mimic/competitor of the GDI activity, in addition to
its macromolecular mimicry and competitive binding to
eIF2 and antagonizing pre-initiation factor complex for-
mation. These activities are potentially opposed to each
other, as weak GDI function with eIF2-GDP could
promote nucleotide exchange and enhance eIF2 recycling.
However binding to eIF2 TC may prevent its product-
ive recruitment to 40S ribosomes and reduce translation
initiation. We therefore decided to examine effects
of 5MP1 expression in yeast, as this has been a sensi-
tive in vivo system for examining translation and its
control.
5MP1 interacts with eIF2 and weakly with eIF3 in
Saccharomyces cerevisiae
We expressed 5MP1 in yeast to take advantage of various
assays established for analyzing eIF2 regulation in trans-
lational control. We ﬁrst examined its interaction with the
yeast translation initiation factor (yeIF) components
in vivo. When overexpressed from the GAL promoter,
FLAG-tagged 5MP1 (FL-5MP1) expressed  25 times
more abundantly than endogenous eIF5 or eIF2 in galact-
ose medium. Anti-FLAG immunoprecipitation (IP)
indicated that  25% of total eIF2 is speciﬁcally associated
with the galactose-induced FL-5MP1 (Figure 5B). We
previously reported that  60% of yeIF5, expressed
Figure 5. The GDI activity test of 5MP1/BZW2 and its interaction with eIFs in yeast S. cerevisiae.( A) GDI assay. Off-rates for eIF2-GDP was
measured in the presence of indicated proteins fused to GST (4). C, Buffer control. Bars and line indicate mean and SD, respectively. Gray ﬁlled
bars, not signiﬁcantly different from buffer alone; unﬁlled bars are signiﬁcant with P-value and the number of experiments (n) shown.
(B) Immunoprecipitation. An amount of 200mg of WCE prepared from H2557 transformants carrying an empty vector (Vec) or pEMBL-FL-
5MP1 (FL-5MP1) which had been grown in SCGal-ura was used for anti-FLAG IP, and entire IP fractions (P), 20% in-put (In) and 10%
supernatant (S) fractions were analyzed by immunoblotting with anti-FLAG (top) and anti-yeIF2a (SUI2) (bottom) antibodies. (C and D)
Afﬁnity-puriﬁcation of FL-5MP1 complexes in yeast. Complexes containing the FLAG-tagged proteins listed across the top were puriﬁed from
H2557 transformants carrying pEMBL-FL-5MP1 (lane 1) or a vector control (lane 2) and KAY50 (TIF5-FL) (lane 3), as described (11). The former
two strains were grown in SCGal-ura medium and the latter was grown in YPD. Portions of the eluates were analyzed by Coomassie Blue staining
(C) and immunoblotting with antibodies raised against yeast eIFs listed to the right (D). In (C), arrowheads indicate the positions of eIF subunit
identiﬁed. Gray labels, eIF2 subunits; Iron labels, eIF3 subunits; Black labels, yeIF5-FL (5-FL) or FL-5MP1. (E) Table summarizes the relative
molar ratio of co-purifying factors, compared to the molarity of eIF2 (Rows 2 and 3) as deﬁned as 1. These ratios were determined in reference to
puriﬁed external standards as described previously (3,21). (F) Models depicting the interaction of FLAG-yeIF5 (panel 1, oval labeled eIF5) and
FLAG-human 5MP1 (panel 2, gray oval) with yeast factors (open ovals). Direct contact, strong interaction; arrow, intermediate interaction; dotted
arrow, weak interaction.
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Because the level of 5MP1/yeIF2 complex was lower
than that of yeIF5/yeIF2 complex even when 5MP1 was
overexpressed, the interaction of 5MP1 with yeast eIF2 is
likely to be weaker than that between yeast eIF5 and eIF2
in vivo.
To investigate the interaction of other MFC compo-
nents with FL-5MP1, we analyzed the eIF constituents
of FL-5MP1 complexes that were puriﬁed by
anti-FLAG afﬁnity chromatography (Figure 5C, lane 1).
As shown in Figure 5C, Coomassie blue staining of the gel
indicated that the FL-yeIF5 immunopuriﬁed sample
contains yeast eIF3, eIF5 and eIF2 (lane 3), representing
part of the MFC, as reported previously (3,11,21). The
FL-5MP1 immunopuriﬁed sample contained three
proteins, which appeared to comigrate with the three
eIF2 subunits (? in lane 1) in quantities roughly equivalent
to those found in the FL-yeIF5 sample (gray arrowheads
in lane 3). The identity of six of the MFC polypeptides was
conﬁrmed by immunoblotting (Figure 5D), and the
relative molar abundances of eIF1, eIF2, eIF3 and eIF5
(compared to eIF2 subunits) were determined using
puriﬁed recombinant proteins as external standards and
presented in Figure 5E. These data showed that the
FL-5MP1 (lane 1) and FL-yeIF5 (lane 3) immunopuriﬁed
fractions contained similar amounts of co-purifying yeIF2
(Rows 2 and 3). Because much more FL-5MP1 was
present in lane 1 than FL-yeIF5 found in lane 3
(Figure 5D and E, Row 1), this also highlighted that the
FL-5MP1 interaction with yeIF2 is likely to be weaker
than yeIF5/yeIF2 interaction. Importantly, yeIF5 was
not detected at all in the FL-5MP1 complex (Figure 5E,
Row 5) providing in vivo evidence that 5MP1 and eIF5
form mutually exclusive complexes with eIF2 (Figure 5F).
This is consistent with each factor competing for the same
interaction site on eIF2. In addition, a small but signiﬁ-
cant amount of yeIF3 was found associated with
immunopuriﬁed FL-5MP1 (Figure 5D and E, Row 4),
consistent with the observed 5MP1 interaction with
human eIF3 (Figure 2D). However, no yeIF1 was
associated with FL-5MP1, indicating that the 5MP1
cannot mimic the role of eIF5 in MFC formation
(Figure 5D and E, Row 6).
5MP1 decreases eIF2 localization to eIF2B-associated
bodies in yeast
Despite the substantial interaction observed between
5MP1 and yeIF2, the 5MP1 overexpression did not
retard the yeast growth rate. To detect any perturbation
in translation initiation in vivo, especially one related to
eIF2 activity, we took an independent cell biology
approach. A signiﬁcant fraction of yeast mother cells
usually harbor a single cytoplasmic body containing
eIF2B (termed the eIF2B body) (34). These are distinct
from other cytoplasmic foci, e.g. the processing bodies,
EGP bodies or stress granules (31–33). Photobleaching
experiments have shown that eIF2B is a ﬁxed component
of this body, while eIF2 is more dynamic, shuttling
through the body. Under conditions that reduce GEF
activity (stress or eIF2B mutations); the rate of eIF2
cycling through the body was signiﬁcantly reduced, sug-
gesting that the eIF2B bodies represent a concentrated site
of nucleotide exchange (34). We predicted that if 5MP1
interacts with yeIF2 and inhibits translation, this would
decrease the shuttling of yeIF2 through the eIF2B bodies.
To test this idea, we introduced the GAL-5MP1 plasmid,
or hc yeIF5 plasmid as a control, to strains bearing
GFP-tagged yeIF2Bg or GFP-tagged yeIF2a. The intro-
duction of neither plasmid affected the frequency or size of
the eIF2B body in the eIF2B-GFP strain (data not
shown). In contrast, when introduced to YMK883 ex-
pressing GFP-eIF2a (Figure 6A inset), we observed that
both the GAL-5MP1 and hc yeIF5 plasmids reduced the
proportion of cells eliciting medium to strong GFP-yeIF2
signals present in the bodies (Figure 6A, graph, Rows 3
and 4; Figure 6B, Row 3), suggesting that eIF2 activity is
reduced by the overexpression of 5MP1 or yeIF5. This
thesis is supported by additional statistical analyses of
the microscopic data; we measured the proportion of the
GFP-yeIF2 signal intensity localized in the eIF2B body,
compared to total GFP-yeIF2 signal intensity in each cell
across an entire population of cells. This value decreased
from 9.2% (vector control) to 2.7 and 4.0% by
overexpression of yeIF5 and 5MP1, respectively
(Figure 6B, Row 4). Importantly, the reduced localization
was restored to normal by introduction of the AA-box 2
mutation to the GAL-5MP1 construct (Figure 6A, column
d; Figure 6B, Rows 3 and 4). This result is the opposite of
the impact of conditions that lead to induced or constitu-
tive eIF2a phosphorylation, under which increased asso-
ciation of GFP-yeIF2 with eIF2B bodies was observed
(34). Thus, the result shown in Figure 6B suggests that
overproduced 5MP1 reduces the rate of shuttling of
yeIF2 through the eIF2B body, by inhibiting yeIF2 re-
cruitment to eIF2B bodies, directly or indirectly, in a
manner that is dependent upon the 5MP1 AA-box 2.
This observation is consistent with excess yeIF5 or
5MP1 exerting an overall negative effect on translation
initiation rates in cells. We explored this idea next using
a genetic strategy.
5MP1 increases the yeast general control response
independently of Gcn2p activation
We reasoned that if 5MP1 directly binds yeIF2, then it
might inﬂuence GCN4 translation, which is activated by
alterations in TC levels and recruitment in a mechanism
similar to that described for ATF4 above. For example,
5MP1 might trigger preferential translation of GCN4, due
to the depletion of eIF2 from the TC (35). This would
be entirely consistent with the effect of 5MP1 on ATF4
translation in the absence of eIF2 phosphorylation
(Figure 4D). Phosphorylation of eIF2 in response to
amino acid starvation in yeast, via the Gcn2p eIF2a
kinase, typically lowers TC abundance and delays the
re-initiation process that otherwise occurs on an uORF
in the GCN4 leader, and instead increases re-initiation at
the GCN4 ORF. We overexpressed 5MP1 to investigate
whether the increased eIF2 binding could deplete the TC
leading to enhance GCN4 translation in a Gcn2p-
independent manner. In practice, this entailed the
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Gcn4p transcriptional target (HIS4) during histidine star-
vation conditions induced by the inhibitor 3-aminotriazole
(3AT). As shown in Figure 7A, Row 1, the growth of a
gcn2D strain is sensitive to 3AT because the absence of
eIF2 phosphorylation prevents the preferential translation
of GCN4 and the subsequent transcriptional induction of
those genes required to alleviate the nutrient starvation.
We envisaged that 5MP1 overexpression might mimic
the effect of eIF2 phosphorylation to confer 3AT resist-
ance to the gcn2D strain. However, 5MP1 expression from
the constitutive SUI1 promoter or GAL promoter did not
confer 3AT resistance to gcn2D strains (data not shown),
although the abundance of 5MP1 expressed from SUI1
and GAL promoters was  12 (Figure 7B) and  25-fold
(see above) higher than that of yeIF2, respectively. We
reasoned that eIF2B mutations known to limit TC levels
could sensitize gcn2D strains to a reduction in eIF2
activities, which might be caused by 5MP1 expression.
Indeed, alteration of either S576 or the AA-box 2 of the
eIF2Be catalytic domain (in the gcd6-S576N gcn2D and
gcd6-7A gcn2D mutant strains, respectively) sensitizes the
strains such that 5MP1 expression now increases the 3AT
resistance (Figure 7A, Rows 3 and 8; Figure 7C, Row 3).
It should be noted that these gcd6 mutant strains are
slightly resistant to high doses of 3AT (Figure 7A, Rows
2 and 7; Figure 7C, Row 2) (8,36) and that expression of
5MP1 provides further increase in this 3AT resistance.
This growth of 5MP1-expressing strains suggests a
modulatory role for 5MP1 in the regulation of translation
initiation. However, its effect on yeast translation is only
kinetic, as examined below, but may not be clearly
physiological.
The overexpression of yeIF5 conferred much stronger
growth in the presence of 3AT in the gcn2D gcd6 strains
than did 5MP1 (Figure 7A, Rows 5 and 10; Figure 7C,
Row 5). This result may reﬂect either the fact that yeIF5 is
expressed at a higher level than 5MP1 (Figure 7B), or that
the yeIF5/yeIF2 interaction is stronger than 5MP1/yeIF2
interaction (Figure 2), or both. The enhanced resistance to
histidine starvation shown by both excess eIF5 and 5MP1
was accompanied by corresponding increase in HIS4-lacZ
expression, whose transcription is activated by Gcn4p
(Figure 7D). Furthermore, both growth and HIS4-lacZ
effects of 5MP1 are alleviated by the 5MP1 AA-box 2
mutation 7A (Figure 7A, C and D) without decreasing
5MP1 abundance (Figure 7B). Overall, these results
suggest that 5MP1 has the capacity to impact upon
GCN4 translation in a manner dependent upon its
AA-box 2. Given the exquisite sensitivity of the GCN4
system to changes in TC recruitment to the ribosome,
these results further suggest that 5MP1 impacts upon the
level or recruitment of TC to the pre-initiation complex.
5MP1 promotes eIF2 TC formation and inhibits MFC
formation in yeast
A key question arising from the experiments described
above is whether 5MP1 impacts upon the levels of
Figure 6. Effect of 5MP1 on GFP-eIF2 association with eIF2B bodies. (A) Inset shows a typical image of yeast YMK883 cell expressing GFP-eIF2,
with its localization in large cytoplasmic eIF2B bodies (34). YMK883 transformants carrying an empty vector (Vec, column a), YEpL-TIF5-FL (hc
yeIF5, column b), pEMBL-FL-5MP1 (5MP1, column c) and pEMBL-FL-5MP1-7A (5MP1-7A, column d) (Supplementary Table S1) were grown in
SCGal-ura medium to a mid-log phase. Then, ﬂuorescent images of the cells were taken under a confocal microscope, and quantiﬁed for the amount
of GFP-eIF2 signal localized in the bodies compared to one in the whole cell. Graph indicates the proportions of the groups of cells (in each column)
with no, weak, medium and strong GFP-eIF2 signals in the bodies, as deﬁned in each row of the graph. (B) Table summarizing the plasmid used
(Row 1), the number of transformed cells measured (Row 2), percentage of cells with med to strong GFP-eIF2 signals in the body (the sum of
percentage values in Rows 3 and 4 of graph in A) (Row 3), and percentage of GFP-eIF2 signals localized in the bodies, averaged for the entire
population of the cells carrying the same plasmid (Row 4), together with its standard error of the mean (SD/n
1/2; Row 5).
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assess this, we quantiﬁed the abundance of
yeIF2-containing complexes. For this purpose, the
HA-tagged 5MP1 (HA-5MP1) was overexpressed in a
strain encoding yeIF2b-FL (encoded by SUI3-FL), and
the initiation components which co-immunoprecipitated
with FLAG-eIF2 were quantitatively analyzed (21).
Immunoblotting indicated that HA-5MP1 was expressed
at approximately four to ﬁve times higher levels than
yeIF5 (data not shown). As shown in Figure 8A, the ex-
pressed HA-5MP1 signiﬁcantly increased TC levels
(P=0.019, n=7), as determined by the amount of
tRNAi
Met immunoprecipitated (see graph 1 to the right).
The reason for this increase will be discussed below.
Importantly, this TC increase was accompanied by a
decrease in yeIF5 and yeIF3b that are co-associated with
FL-yeIF2 (Figure 8A, graph 2 and 3, respectively,
P< 0.05, n=3). This decrease in the interaction of both
eIF5 and eIF3 with FL-yeIF2 implicates HA-5MP1 in the
inhibition of MFC formation.
To conﬁrm and extend these observations, we next
examined the impact of 5MP1 expression on the
yeIF3-containing complexes. Hence, we overproduced
FL-5MP1 in a strain encoding the HA-tagged yeIF3i
subunit. As shown in Figure 8B, less yeIF2a co-precipitated
with HA-yeIF3 in the presence of FL-5MP1 (lane 7) than in
its absence (lane 6). Because eIF2/eIF3 association depends
on bridging by eIF5, this is the hallmark of MFC forma-
tion. Thus, these results conﬁrm that FL-5MP1 indeed
inhibits MFC formation. The more dramatic effect on
MFC relative to Figure 8A is likely due to a higher expres-
sion level of this FL-5MP1 construct than that of
HA-5MP1. The 5MP1-mediated inhibition of MFC forma-
tion was alleviated by the AA-box 2 mutation 7A
introduced to FL-5MP1 (Figure 8B, lane 8). Since 5MP1
expression did not reduce the interaction of HA-yeIF3 with
Figure 7. 5MP1 overexpression increases GCN4 translation in gcn2D gcd6 backgrounds. (A) Yeast dilution assays. Transformants of KAY16 (Row
1), GP3578 (Rows 2–5), KAY33 (Row 6) and KAY34 (Rows 7–10) carrying an empty vector (Vec), YEpL-FL-5MP1 (5MP1 in Row 3), YEpL-FL-
5MP1-7A (5MP1-7A in Row 4), YEpTIF5-FL (yeIF5 in Row 5), YEpU-FL-5MP1 (5MP1 in Row 8), YEpU-FL-5MP1-7A (5MP1-7A in Row 9),
and YEpU-TIF5 (yeIF5 in Row 10) were grown in SC-His-Leu or SC-His-Ura medium. Fixed amounts (A600=0.15) of the culture and its 10-fold
serial dilutions were spotted onto the agar plates of the same medium without or with indicated amounts of 3AT and incubated at 30 C for 2 and 6
days, respectively. (B) Expression check. Indicated amounts of WCE prepared from KAY16 transformants carrying the plasmids used in (A) Rows
1–5 were subjected for immunoblotting with antibodies listed to the left. Bottom; molar amounts of FLAG-tagged proteins present in WCE were
determined using 40ng puriﬁed FL-5MP1 (lane 9) as standard, and compared to known amount of yeIF2 present in WCE (21). (C) Cultures of
KAY33 (Row 1) or KAY34 (Rows 2–5) transformants carrying an empty vector (Vec), pEMBL-FL-5MP1 (5MP1), pEMGL-FL-5MP1-7A
(5MP1-7A) and YEpU-TIF5 (yeIF5) were spotted and incubated as in (A), except that they were grown in SCGal-His-Ura medium. (D)
Expression from chromosomally integrated HIS4-lacZ in transformants used in Panel A, Rows 10–13 and 5–8 were presented by b-galactosidase
units. P-values for the differences indicated by arrows are: *, 0.004; **, 0.035; *** and ****, <0.00001.
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with yeIF3 binding to yeIF5 in yeast, consistent with the
weak interaction observed between FL-5MP1 and yeIF3
(Figure 5D and E). These observations suggest that
5MP1 inhibits TC binding to the 40S subunit, primarily
by sequestering TC away from yeIF5 and yeIF3, which
otherwise promote TC binding to the 40S subunit
(Figure 8C, Model 1). This would mean that an inhibition
of TC recruitment would explain why 5MP1 enhanced
GCN4 translation in the gcn2D gcd6 mutant strains
(Figure 7).
DISCUSSION
In this article, we have assessed the function of the human
MA3-W2 HEAT repeat protein previously called BZW2
and here renamed as 5MP1. We have shown that the
Figure 8. Effect of 5MP1 on the abundance of eIF complexes in yeast. (A) Quantitative anti-FLAG IP. An amount of 1mg of WCE prepared from
KAY107 (TIF34-3HA) transformant carrying an empty vector (C), KAY128 (SUI3-FL) transformants carrying an empty vector (V) or pEMBL-HA-
5MP1 (5MP) was used for anti-FLAG IP and 80% (top gel) and 20% (bottom gels) of the precipitated fractions (lanes under aFLAG IP) were
analyzed by northern and western blotting, respectively, with 2% in-put amount (lanes under In-put), as described (21). HA or FLAG-tagged alleles
present in the transformants are indicated across the top. Graphs to the right summarize the relative amount of indicated components associated with
FLAG-eIF2, after correction by the amount of eIF2a precipitated. (B) Co-IP with HA-eIF3. An amount of 200mg of WCE prepared from KAY127
(SUI3-FL) transformant carrying an empty vector (C), KAY113 (TIF34-3HA) transformants carrying an empty vector (V), pEMBL-FL-5MP1
(HP), or pEMBL-FL-5MP-7A (7A) was used for anti-HA IP, and entire IP fractions and 10% in-put amounts were analyzed by immunoblotting
with antibodies raised against HA-epitope (top) and yeast eIF2a (bottom). (C) Possible models to explain increased TC abundance by 5MP1 in
yeast. Numbers in circles refer to eIFs (e.g. 1, eIF1). Gray squares, 5MP1. Model 1. 5MP1/TC interaction slows down MFC formation (dotted
arrow). The accumulation of 5MP1/TC complex contributes to increase in overall TC abundance (both free TC and TC/5MP1). Model 2. 5MP1/
eIF2-GDP interaction antagonizes the GDI function (stopped bar to GDP) of eIF5. The steps of GDI and GEF are highlighted with light gray
round squares.
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in vitro (Figure 2). Together with the ﬁnding that the
5MP1 Drosophila homolog, Kra, interacts with eIF2b,
this result strengthens the idea that translation factors
and regulators with the W2-type HEAT domains (i.e.
eIF5, eIF2Be and p97/NAT1/DAP5) can generally
interact with eIF2. We also showed that 5MP can
modulate overall translation (Figure 4C) and transla-
tion of a luciferase reporter gene in RRL (Figure 3A).
These observations suggest that 5MP binding to eIF2
(and perhaps eIF3) can modulate the efﬁciency of
protein synthesis.
How does 5MP regulate protein synthesis?
5MP interacts directly with eIF2 or eIF3 (Figure 2), and
therefore could competitively inhibit or even replace the
functional interactions of any of the W2-domain contain-
ing proteins such as eIF5 or eIF2Be. Our in vitro studies
directly examining the effect of 5MP on GDP binding to
eIF2 showed that the human 5MP1 is not a GEF, but
instead has weak GDI activity for eIF2 (Figure 5A).
GDI activity was recently ascribed to yeast eIF5 as a
second function in addition to its GAP activity (4).
Therefore eIF5 GAP activity switches eIF2 into an
inactive GDP-bound state, and its GDI activity prevents
reactivation of eIF2 by the GEF eIF2B. Similarly the
observed inhibition of GDP release by 5MP1 (GDI
activity) could contribute to locking eIF2 in an inactive
state; however, because 5MP1 GDI activity is weak,
5MP1/eIF2-GDP binding may antagonize eIF5 GDI
and therefore promote GDP release. Consistent with this
idea, we made an interesting observation that 5MP1
overexpression increases TC (eIF2-GTP-Met-tRNAi
Met)
abundance (Figure 8A). These observations led us to
propose one mechanism for 5MP function (Figure 8C,
Model 2). In this model, 5MP1 expression would
compete directly with eIF5 GDI function, resulting in an
increase in TC abundance by preventing eIF5
antagonizing the GEF activity of eIF2B. However an al-
ternative explanation is also possible (see below).
The ability of 5MP1 to interact with both eIF2 and eIF3
(Figure 2A, B and D) strengthened the idea that 5MP1
could function as a competitive inhibitor and structural
mimic of eIF5 functions in pre-initiation multifactor
complex (MFC) assembly necessary for efﬁcient transla-
tion initiation by the standard scanning model. This model
is supported by a number of experimental observations.
First, 5MP1 can bind eIF2b in competition with eIF5
(Figure 2C). Second, 5MP1 can compromise eIF5
co-migration with 40S ribosomes in the RRL
(Figure 3B). Third, 5MP1 complex with yeast eIF2 does
not include eIF5 (Figure 5D) and ﬁnally it can antagonize
the binding of eIF2 TC to eIF3, which is necessary
for MFC formation in yeast (Figure 8B). This latter
observation provides an alternative explanation for
the observed increase in TC levels following 5MP1
expression (Figure 8A). The observations are consistent
with a fraction of TC becoming sequestered into a
TC/5MP1 complex and being unavailable for MFC
assembly. This idea is also shown diagrammatically in
Figure 8C (Model 1). Thus, 5MP can act as a competitive
inhibitor of eIF5 functions in promoting the assembly of
the ribosomal pre-initiation complex, or act to antagonize
eIF5 GDI function and thereby act positively to promote
GEF function. Either or both of the models together
could account for the observed increase in TC. We also
acknowledge that the effect of the human 5MP1 on yeast
translation is overall weak and not clearly physiological,
perhaps owing to the evolutionary distance from the
model organism. To take better advantage of the yeast
system, it would be attractive to study the effect of
5MP from lower eukaryotes (16), those from fungi
(Basidiomycota), in particular.
Is 5MP a part of inhibitory mRNP complexes?
The models proposed in Figure 8C consider the inhibitory
effect of 5MP1 on eIF2, as observed in yeast. Because
5MP1 can also interact with eIF3 (Figure 2D), its effect
on translation in mammalian cells could be more complex.
For example, with a link to eIF3, 5MP1 that lacks the
GAP domain might replace eIF5 recruitment to the 40S
subunit (Figure 3B) and thereby prevent 60S subunit
joining. An alternative, but not mutually exclusive, idea
consistent with its partial effect on translation in mamma-
lian cells (Figure 4C) is that effective translational control
by this protein requires additional binding proteins in
complex with 5MP1, eIF2 and eIF3. In agreement with
this idea, evidence was provided previously that the
Drosophila homolog Kra binds simultaneously to eIF2
and Shot, a cytoskeletal element. Furthermore, Kra
co-expresses with the mRNA-speciﬁc binding factors
Pumilio and Staufen in certain areas of the central
nervous system, suggesting that Kra is a component of
multiple inhibitory mRNA/protein (mRNP) complexes
(20). Speciﬁc expression of Kra in cholinergic local
neurons of antennal lobe has been established and a
krasavietz enhancer trap line is frequently used to study
Drosophila CNS function (37). Together these ﬁndings
suggest an intriguing possibility that 5MP1 and eIF2
form part of a larger translationally repressed mRNA
complex that are undergoing cytoskeleton-mediated intra-
cellular transport. The observed GDI activity of 5MP1
(Figure 5A), if it occurs in vivo, would inhibit GDP dis-
sociation during the transport process in favor of transla-
tional inhibition. A 5MP interaction with cytoskeletal
elements in humans was suggested previously by the
physical interaction of human BZW1/5MP2 with
PSTPIP1 (38), which in turn interacts with Wiskott-
Aldrich Syndrome Protein (39). The latter two proteins,
which regulate F-actin formation, are expressed predom-
inantly in hematopoietic cells, where higher levels of
BZW1/5MP2 transcripts are also observed (40).
Although work to address these ideas is beyond the
scope of the present manuscript, it is one avenue to
pursue in the future.
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